cell therapy company utilizing proprietary autologous tumor infiltrating lymphocytes (TILs) to attack solid tumors. Conducting pivotal stage trial in metastatic melanoma and cervical cancer, with BLA expected 2020, Additional company-sponsored trials: head & neck cancer, non-small cell lung cancer, and earlier lines in melanoma. IST collaborations in ovarian cancer, bladder cancer, sarcomas, adenocarcinoma, and pancreatic cancer.
US - Pacific
999 Skyway Road
San Carlos, CA 94070
Top 10 Holders of Iovance Biotherapeutics Inc
Ownership data is sourced through FactSet.
Stock Market Data
Market Data copyright © 2020 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by